ciraparantag

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2017
012320152017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Of the new direct oral anticoagulants, direct factor Xa inhibitors are limited by the absence of a proven reversal agent. We… (More)
Is this relevant?
Review
2017
Review
2017
PURPOSE The available clinical data on target-specific oral anticoagulant (TSOAC) reversal agents that are currently in… (More)
  • table 1
Is this relevant?
Review
2017
Review
2017
Reversal agents for direct oral anticoagulants (DOACs), including factor X inhibitors and direct thrombin inhibitors, are a major… (More)
  • table 1
Is this relevant?
2016
2016
Major bleeding with low molecular weight heparin (LMWH) therapy occurs in up to 5% of patients and its anticoagulation is only… (More)
Is this relevant?
Review
2016
Review
2016
Novel oral anticoagulants (NOACs) are increasingly used in clinical practice, but lack of commercially available reversal agents… (More)
  • table 1
  • figure 1
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2016
Review
2016
Oral Factor Xa (FXa) inhibitors, a growing class of direct-acting anticoagulants, are frequently used to prevent stroke and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
As expected with all antithrombotic agents, there is a risk of bleeding complications in patients receiving direct oral… (More)
Is this relevant?
Review
2016
Review
2016
Patients taking direct oral anticoagulants (DOACs) who then need an emergency invasive procedure require specialized management… (More)
  • table 1
  • table 2
  • table 2
Is this relevant?
Review
2016
Review
2016
In recent years, non-vitamin K oral anticoagulants (NOACs) have emerged as an alternative to warfarin for the prevention and… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2015
Review
2015
Although there is controversy about the absolute need for a reversal agent for the new direct oral anticoagulants (DOACs), the… (More)
  • table 1
Is this relevant?